Kijimea PRO

Kijimea PRO is a specialized probiotic medical food developed by Synbiotix, a German company focused on microbiome research. The product is internationally recognized for its use of the patented heat-inactivated strain B. bifidum MIMBb75, which was specifically engineered to address gastrointestinal issues such as irritable bowel syndrome (IBS) and gut barrier dysfunction.

The brand's journey began with a focus on 'probiotic science,' leading to clinical trials that established its efficacy across several European markets before expanding globally. Today, the manufacturing process adheres to strict pharmaceutical standards, predominantly conducted in Germany and Italy to ensure the stability of the sensitive microbial strains.

Ownership of Kijimea resides with Synbiotix GmbH, headquartered in Munich, Germany. The company remains an independent entity dedicated to the research and distribution of medical-grade probiotics, leveraging local distributors for their international reach in regions like North America and across the European Union.